J. de Mouzon

ORCID: 0000-0002-9465-3488 · 5 papers in corpus
article 2020
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2020.11.017

Research questionDoes endometriosis increase obstetric and neonatal complications, and does assisted reproductive technology (ART) cause additional risk of maternal or fetal morbidity?DesignA nationwide cohort study (2013-2018) comparing ma…

article 2012
Human Reproduction ·doi:10.1093/humrep/des274

STUDY QUESTION: Are anti-Müllerian hormone (AMH) levels lower in women with endometriosis, notably those with endometriomas (OMAs) and deep infiltrating lesions, compared with controls without endometriosis? SUMMARY ANSWER: Endometriosis an…

article 2010
Fertility and sterility ·doi:10.1016/j.fertnstert.2010.05.056

In women with endometriosis, including those with endometriomas, 6 to 8 weeks of continuous use of oral contraception (OC) before assisted reproduction treatment (ART) maintains ART outcomes comparable with the outcomes of age-matched contr…

article 2007
·doi:10.1093/humrep/dem1053

Objectives: To evaluate the effect of the levonorgestrel-releasing intrauterine system (LNG-IUS) on adenomyotic lesions diagnosed and monitored by magnetic resonance imaging (MRI). Design: A prospective descriptive study. Setting: Tertiary …

article 2006
·doi:10.1016/j.fertnstert.2006.07.432